Showing 43,301 - 43,320 results of 62,523 for search '(( 5 ((step decrease) OR (we decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 43301
  2. 43302
  3. 43303
  4. 43304
  5. 43305

    Effects of treatment with mTORC1 blocker rapamycin on taste cells. by Shingo Takai (7853843)

    Published 2019
    “…<p>(A, B) Confocal images of taste organoids at day 20, cultured in conditioned medium (CM) with 20 ng/ml rapamycin plus 50 nM insulin (A) or 0 nM insulin (B). …”
  6. 43306

    Short-Term Effects of Experimental Warming and Precipitation Manipulation on Soil Microbial Biomass C and N, Community Substrate Utilization Patterns and Community Composition by LI, Guanlin

    Published 2017
    “…Decreased and increased precipitation significantly reduced microbial biomass C by 13.5% and 24.9% and microbial biomass N by 22.9% and 17.6% in unwarmed plots, respectively (P < 0.01). …”
    Get full text
    Get full text
  7. 43307

    Source Data file.xlsx by Chan Lu (19963167)

    Published 2024
    “…We found that co-exposure to high temperature and NO<sub>2</sub> elevated blood glucose levels and exacerbated histopathological changes. …”
  8. 43308

    Rapid Suppression of Activated Rac1 by Cadherins and Nectins during <em>De Novo</em> Cell-Cell Adhesion by Khameeka N. Kitt (227731)

    Published 2011
    “…Upon initiation of cell-cell contact in 3-D cell aggregates, we observed an initial peak of Rac1 activity that rapidly decreased by ∼66% within 5 minutes, and further decreased to a low baseline level after 30 minutes. …”
  9. 43309

    Methylation of <em>Wnt7a</em> Is Modulated by DNMT1 and Cigarette Smoke Condensate in Non-Small Cell Lung Cancer by Meredith A. Tennis (179612)

    Published 2012
    “…The <em>Wnt7a</em> promoter has a higher percentage of methylation in NSCLC tumor tissue compared to matched normal lung tissue and methylation of the promoter region leads to decreased activity. We treated H157 and H1299 NSCLC cell lines with 5-Aza-2′-deoxycytidine and detected loss of <em>Wnt7a</em> promoter methylation, increased Wnt7a expression, and increased activity of the Wnt7a lung signaling pathway. …”
  10. 43310
  11. 43311

    Riociguat prevents hyperoxia-ablated vascular development. by Keyur Donda (5497400)

    Published 2018
    “…<p>(<b>A</b>) Immunofluorescence staining for von-Willebrand factor (vWF) (green signal). …”
  12. 43312
  13. 43313
  14. 43314

    Intersection between the set of genes within the R1-R4 genomic regions and the sets of genes covered by online cvxNDL dictionary elements for chr2L. by Vishal Rana (18570649)

    Published 2024
    “…<p>We determined the sizes of the intersections of the set of genes covered by each dictionary element and the genes in the R1-R4 genomic region and arranged them in decreasing order. …”
  15. 43315

    Table1_Echocardiography-guided percutaneous intramyocardial alginate hydrogel implants for heart failure: canine models with 6-month outcomes.docx by Hui Ma (290168)

    Published 2024
    “…Compared with controls at 6-month, PIMAHI group significantly increased LVFW thickness (8.5 ± 0.3 vs. 6.8 ± 0.2 mm, p = 0.002) and IVS (7.9 ± 0.1 vs. 6.1 ± 0.2 mm, p < 0.001); decreased LVEDV (30.1 ± 1.6 vs. 38.9 ± 4.5 ml, p = 0.049) and ESV (17.3 ± 1.2 vs. 28.7 ± 3.6 ml, p = 0.004); increased LV systolic function (42.7 ± 1.5 vs. 26.7 ± 1.1% in EF, p = 0.001); and enhanced LV myocardial contractility including GLS (13.5 ± 0.8 vs. 8.4 ± 0.6%, p = 0.002), GCS (16.5 ± 1.4 vs. 9.2 ± 0.6%, p = 0.001), and MAD (11.4 ± 3.5vs 4.6 ± 2.5 mm, p = 0.003). …”
  16. 43316

    Data Sheet 1_Plausibility of super high-flux dialyzer reuse in maintenance hemodialysis.pdf by Piyapun Prapunwatana (22474063)

    Published 2025
    “…Dialysate albumin loss decreased significantly from 1.01 g during the 1st use to 0.19 g during the 2nd and 0.06 g during the 5th use (p-value < 0.001). …”
  17. 43317

    Acquisition of plasmid-mediated cephalosporinase producing <i>Enterobacteriaceae</i> after a travel to the tropics by Florian Lorme (6095348)

    Published 2018
    “…The carriage of pAmpC-E decreased quickly after return with 92.5% of colonized travelers being negative at one month. …”
  18. 43318

    Image_4_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  19. 43319

    Image_3_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  20. 43320

    Image_1_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”